ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,242 | +146.8% | 143,350 | +141.5% | 0.87% | +248.2% |
| Q2 2023 | $1,189,968 | +17.0% | 59,350 | 0.0% | 0.25% | -26.4% |
| Q1 2023 | $1,016,666 | -12.2% | 59,350 | 0.0% | 0.34% | -22.3% |
| Q4 2022 | $1,157,325 | +65.8% | 59,350 | +19.3% | 0.44% | +72.8% |
| Q3 2022 | $698,000 | +104.7% | 49,750 | +101.0% | 0.25% | +124.8% |
| Q2 2022 | $341,000 | – | 24,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |